Purchase Order HT001423P0027
Award Date 1/31/23
Potential Completion Date 12/31/27
Potential Value $137K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Cheraw, CO 81030, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm-fixed price purchase order contract awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer of in vitro diagnostics, reagents, and blood banking supplies. The $514,572.15 contract is for the delivery of unspecified supplies, with a period of performance ending on September 30, 2023. No set-aside designation was used. Immucor is an experienced federal contractor, having previously provided a variety of medical products and services to agencies such as the...
- This firm fixed-price federal contract award to Immucor Inc. is for the provision of in-vitro diagnostic substances and related manufacturing services. The $20,000.00 contract was issued by the Defense Health Agency (DHA), a component of the Department of Defense, and has an ultimate completion date of September 30, 2022. The award does not have a set-aside designation. Immucor Inc. is a for-profit manufacturer specializing in automated blood testing equipment, reagents, and consumables for...
- This federal contract was awarded by the Defense Health Agency (DHA) to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products for blood transfusion and transplantation testing. The contract, valued at $209,111.24, is for the delivery of CLIN reagents and supplies. It is a firm fixed-price Blanket Purchase Agreement (BPA) call order with a completion date of March 13, 2019. Immucor has a history of providing specialized reagents, blood analyzers, testing equipment, and related...
- This is a firm fixed-price purchase order awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer, for the delivery of medical supplies such as fetal blood screen kits, blood cells, and PanoCell products. The potential value of the contract is $216,898.69, with a performance period through April 24, 2023. The contract does not have a set-aside designation. Immucor has previously been awarded federal contracts to provide blood banking supplies, reagents, and testing...
- This is a $14,557.30 firm fixed price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Immucor Inc., a for-profit manufacturer of blood transfusion and transplantation diagnostics. The contract is for the delivery of unspecified in vitro diagnostic products, reagents, and test kits to support the blood typing, compatibility testing, and other blood banking operations required by the NIH Clinical Center. The contract does not have a set-aside...
- This is a firm fixed-price delivery order contract awarded by the Defense Health Agency (DHA) to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products for transfusion and transplantation testing. The contract, valued at $229,713.76, is for the procurement of Fiscal Year 2023 Immucor consumables under the agency's General Services Administration (GSA) Schedule 65-VII for In Vitro Diagnostics, Reagents, and Tests. This contract does not have a set-aside designation. Immucor holds...
- This federal contract award to Immucor Inc., a for-profit manufacturer, is for the provision of reagents and an echo analyzer to support blood bank operations. The $784,855.51 firm fixed price purchase order was awarded on October 1, 2016 by the Medical Command division of the Department of Defense, with a period of performance through September 30, 2019. No set-aside designation was used. Immucor has previously provided a variety of in vitro diagnostic products, reagents, test kits, and blood...
- This is a firm fixed-price delivery order contract awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer of automated blood testing equipment, reagents, and consumables. The contract, valued at $54,457.50, is for the provision of blood typing equipment and reagents. The contract does not have a set-aside designation. Immucor Inc. is a key supplier of specialized blood banking technologies and supplies that support medical testing and healthcare operations across federal...
- This federal contract award, valued at $244,758.17, was issued by the Defense Health Agency to Immucor Inc., a manufacturer of goods, for the delivery of CAP R RS (3) 5 PLATE DOMESTIC. The contract is a firm fixed-price purchase order without a set-aside designation, with a period of performance through May 31, 2024. Immucor is a leading provider of automated instrument-reagents systems and consumables for blood transfusion and transplantation compatibility testing. The company has a history...
- This is a Delivery Order contract awarded to Immucor Inc., a manufacturer of in vitro diagnostic reagents, test kits, and blood banking equipment. The contract was awarded by the Defense Health Agency (DHA) for $227,628.11 and has a period of performance ending on September 30, 2021. The contract is not designated as a set-aside. Immucor provides specialized reagents, blood analyzers, and related consumables to enable blood typing, compatibility testing, antibody screening, and critical blood...